Literature DB >> 10962384

Non invasive prediction of severe fibrosis in patients with alcoholic liver disease.

A Tran1, P Hastier, E M Barjoan, N Demuth, C Pradier, M C Saint-Paul, E Guzman-Granier, P Chevallier, C Tran, F Longo, S Schneider, T Piche, X Hebuterne, S Benzaken, P Rampal.   

Abstract

OBJECTIVES: The aim of this study was to assess the diagnostic accuracy of noninvasive markers of liver fibrosis in alcoholic liver disease. PATIENTS AND METHODS: Fifty-four clinical and biochemical parameters including serum fibrosis markers (hyaluronate and transforming growth factor beta1) were analyzed in 146 consecutive heavy drinkers (106 men, 40 women; mean age 49.2 years). Following liver biopsy, fibrosis was evaluated using a semi-quantitative scoring system (no fibrosis (0) to severe fibrosis (3 + )). Multivariate analysis was performed to determine the markers that were best correlated with the fibrosis score.
RESULTS: Fifty-nine patients (40.4 %) had severe fibrosis (3 +) while 87 (59.6 %) had no fibrosis or moderate fibrosis (0 to 2 +). In multivariate analysis, serum hyaluronate and the prothrombin index were the best markers for the prediction of severe fibrosis. Hyaluronate and the prothrombin index had a diagnostic accuracy of 91.1 % and 89.7 %, respectively in the whole population. Finally, a significant negative correlation was found between hyaluronate and the prothrombin index (r =- 0.86, P <0.0001).
CONCLUSIONS: Using only hyaluronate and the prothrombin index, 9 out of 10 alcoholic patients can be correctly classified according to the severity of liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962384

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  9 in total

Review 1.  Non-invasive diagnosis of alcoholic liver disease.

Authors:  Sebastian Mueller; Helmut Karl Seitz; Vanessa Rausch
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 2.  Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.

Authors:  Rosa Lombardi; Elena Buzzetti; Davide Roccarina; Emmanuel A Tsochatzis
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

3.  Relationship between clinical and pathologic findings in patients with chronic liver diseases.

Authors:  Lun-Gen Lu; Min-De Zeng; Yi-Min Mao; Ji-Qiang Li; De-Kai Qiu; Jing-Yuan Fang; Ai-Ping Cao; Mo-Bin Wan; Cheng-Zhong Li; Jun Ye; Xiong Cai; Cheng-Wei Chen; Ji-Yao Wang; Shan-Ming Wu; Jin-Shui Zhu; Xia-Qiu Zhou
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

4.  Serum hyaluronic acid: a promising marker of hepatic fibrosis in chronic hepatitis B.

Authors:  Gamal Shiha
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

5.  Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters.

Authors:  Lun-Gen Lu; Min-De Zeng; Mo-Bin Wan; Cheng-Zhong Li; Yi-Min Mao; Ji-Qiang Li; De-Kai Qiu; Ai-Ping Cao; Jun Ye; Xiong Cai; Cheng-Wei Chen; Ji-Yao Wang; Shan-Ming Wu; Jin-Shui Zhu; Xia-Qiu Zhou
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

6.  Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.

Authors:  Bin-Bin Zhang; Wei-Min Cai; Hong-Lei Weng; Zhong-Rong Hu; Jun Lu; Min Zheng; Rong-Hua Liu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

7.  Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease.

Authors:  Julie Parkes; Indra Neil Guha; Scott Harris; William Mc Rosenberg; Paul J Roderick
Journal:  Comp Hepatol       Date:  2012-12-28

8.  The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease.

Authors:  Stéphanie Patouraux; Stéphanie Bonnafous; Cosmin S Voican; Rodolphe Anty; Marie-Christine Saint-Paul; Maria-Alessandra Rosenthal-Allieri; Hélène Agostini; Micheline Njike; Nadége Barri-Ova; Sylvie Naveau; Yannick Le Marchand-Brustel; Pascal Veillon; Paul Calès; Gabriel Perlemuter; Albert Tran; Philippe Gual
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

Review 9.  Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies.

Authors:  Olga Hilda Orasan; George Ciulei; Angela Cozma; Madalina Sava; Dan Lucian Dumitrascu
Journal:  Clujul Med       Date:  2016-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.